ROBERT SIEGEL, host: In 2004, Merck pulled its painkiller Vioxx from the market. The drug was causing heart problems, strokes and deaths among patients in a large study that was under way at the time.
A new study suggests the standard panel size for primary care physicians, about 2,500 patients, is “neither accurate nor reasonable.” For the study, published in the Journal of the American Board of ...
In a recent study published in The Lancet, researchers performed an implementation study of a 12-gene pharmacogenetic panel across seven European countries to investigate whether a gene-drug ...
OKLAHOMA CITY, Okla.--(BUSINESS WIRE)--Moleculera Labs, Inc., a precision medicine, autoimmune neurobiology company, today announced the online publication of a study in the Journal of Neuroimmunology ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results